These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16273996)

  • 21. Immunological approach for the treatment of Alzheimer's disease.
    Solomon B
    J Mol Neurosci; 2003; 20(3):283-6. PubMed ID: 14501009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Zhang Y; Zou J; Yang J; Yao Z
    Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).
    Pradier L; Blanchard-Brégeon V; Bohme A; Debeir T; Menager J; Benoit P; Barneoud P; Taupin V; Bertrand P; Dugay P; Cameron B; Shi Y; Naimi S; Duchesne M; Gagnaire M; Weeden T; Travaline T; Reczek D; Khiroug L; Slaoui M; Brunel P; Fukuyama H; Ravetch J; Canton T; Cohen C
    Alzheimers Res Ther; 2018 Nov; 10(1):117. PubMed ID: 30486882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice.
    Chauhan NB; Siegel GJ; Lichtor T
    J Neurosci Res; 2004 Dec; 78(5):732-41. PubMed ID: 15478192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy.
    Da Mesquita S; Papadopoulos Z; Dykstra T; Brase L; Farias FG; Wall M; Jiang H; Kodira CD; de Lima KA; Herz J; Louveau A; Goldman DH; Salvador AF; Onengut-Gumuscu S; Farber E; Dabhi N; Kennedy T; Milam MG; Baker W; Smirnov I; Rich SS; ; Benitez BA; Karch CM; Perrin RJ; Farlow M; Chhatwal JP; Holtzman DM; Cruchaga C; Harari O; Kipnis J
    Nature; 2021 May; 593(7858):255-260. PubMed ID: 33911285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide.
    Istrin G; Bosis E; Solomon B
    J Neurosci Res; 2006 Aug; 84(2):434-43. PubMed ID: 16767774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.
    Wilcock DM; DiCarlo G; Henderson D; Jackson J; Clarke K; Ugen KE; Gordon MN; Morgan D
    J Neurosci; 2003 May; 23(9):3745-51. PubMed ID: 12736345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
    J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A limited role for microglia in antibody mediated plaque clearance in APP mice.
    Garcia-Alloza M; Ferrara BJ; Dodwell SA; Hickey GA; Hyman BT; Bacskai BJ
    Neurobiol Dis; 2007 Dec; 28(3):286-92. PubMed ID: 17822910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
    Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
    J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
    Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
    J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta.
    Mitrasinovic OM; Murphy GM
    Neurobiol Aging; 2003 Oct; 24(6):807-15. PubMed ID: 12927763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.
    Wang J; Hara H; Makifuchi T; Tabira T
    J Alzheimers Dis; 2008 Jun; 14(2):161-73. PubMed ID: 18560128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
    Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Park MH; Lee M; Nam G; Kim M; Kang J; Choi BJ; Jeong MS; Park KH; Han WH; Tak E; Kim MS; Lee J; Lin Y; Lee YH; Song IS; Choi MK; Lee JY; Jin HK; Bae JS; Lim MH
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23426-23436. PubMed ID: 31685616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.